Whole Blood Controls Monitor Immunosuppressant Drug Test Precision
By LabMedica International staff writers Posted on 29 Oct 2012 |

Image: Five levels of Lyphocheck Whole Blood Immunosuppressant Control (Photo courtesy of Bio-Rad).
A lyophilized, third party, human whole blood based control offers five individual levels and includes Cyclosporine, Tacrolimus, and Sirolimus.
The control can be used with immunoassay or chromatographic techniques. Called the Lyphochek Whole Blood Immunosuppressant Control, it was designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug test procedures in the clinical laboratory from low to very high concentrations. Immunosuppressant drugs are typically used in transplant therapy to help minimize organ rejection. Lyphochek Control is supplied as a whole blood based material that can be processed in the same manner as patient samples.
Bio-Rad Laboratories, Inc. (Hercules, CA, USA), a manufacturer and distributor of life science clinical diagnostics and research products, released the Lyphochek Whole Blood Immunosuppressant Control.
The company offers technical support and troubleshooting assistance for the control. The Unity Interlaboratory Program and the Unity Real Time, a data management-software solution designed to improve the effectiveness of quality control processes, are available for use with the Lyphochek Control.
Related Links:
Bio-Rad Laboratories - TDM controls
Bio-Rad Laboratories, Inc.
The control can be used with immunoassay or chromatographic techniques. Called the Lyphochek Whole Blood Immunosuppressant Control, it was designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug test procedures in the clinical laboratory from low to very high concentrations. Immunosuppressant drugs are typically used in transplant therapy to help minimize organ rejection. Lyphochek Control is supplied as a whole blood based material that can be processed in the same manner as patient samples.
Bio-Rad Laboratories, Inc. (Hercules, CA, USA), a manufacturer and distributor of life science clinical diagnostics and research products, released the Lyphochek Whole Blood Immunosuppressant Control.
The company offers technical support and troubleshooting assistance for the control. The Unity Interlaboratory Program and the Unity Real Time, a data management-software solution designed to improve the effectiveness of quality control processes, are available for use with the Lyphochek Control.
Related Links:
Bio-Rad Laboratories - TDM controls
Bio-Rad Laboratories, Inc.
Latest Hematology News
- Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
- Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
- First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Channels
Clinical Chemistry
view channel
Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Diagnosing elevated uric acid (UA) levels—an important indicator for conditions like gout, chronic kidney disease, and metabolic syndrome—typically requires blood draws, lab equipment, trained technicians,... Read more
Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
Prostate cancer can be difficult to detect early, limiting timely and appropriate treatment. While calcification—calcium build-up in soft tissues—has previously been suggested as a possible indicator,... Read moreMolecular Diagnostics
view channel
Noninvasive Prenatal Test Detects Inherited Conditions
When a pregnant patient is identified as a carrier of a recessive single-gene condition, guidelines recommend testing the biological father to assess the baby’s risk. However, in some cases, the father... Read more
Ultra-Sensitive Diagnostic Test Could Transform Global Health Care
Infectious diseases cause over 10 million deaths worldwide each year, with low-income countries bearing the greatest burden. Limited access to reliable diagnostic tools, costly equipment, and shortages... Read more
Rapid Test Detects Early Signs of Pneumonia in Critically Ill Patients
Hospital-acquired infections (HAIs) remain a significant source of life-threatening illness in intensive care, demanding fast and accurate diagnosis to ensure effective treatment. Hospital-acquired pneumonia... Read more
Cell-Free RNA Test Could Detect Molecular Fingerprints of Chronic Fatigue Syndrome in Blood
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition with symptoms such as exhaustion, dizziness, disturbed sleep, and cognitive impairment. These symptoms often overlap... Read moreImmunology
view channel
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers
Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response
A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more
AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness
One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read moreMicrobiology
view channel
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
AI Tools Analyze Kidney Disease at Cellular Level to Help Tailor Treatments
Doctors treating kidney disease have traditionally relied on trial-and-error to identify the most effective therapies, a process hampered by inconsistent diagnostic tools and an incomplete understanding... Read moreTechnology
view channel
Skin Patch Detects Biomarkers in Interstitial Fluid Without Blood Draws
People with diabetes often need to check their blood glucose levels multiple times a day, a process that typically involves finger-pricking for blood samples or the insertion of a microfilament sensor... Read more
Handheld Saliva Test Accurately Detects Breast Cancer
Breast cancer affects approximately one in eight women, and early detection through screening significantly increases the chances of successful treatment. While mammograms and MRIs are effective, many... Read moreIndustry
view channel
WHO Releases Updated Guidance on Tuberculosis Diagnosis
Tuberculosis remains a major global health challenge, with timely detection critical to preventing disease spread and improving treatment outcomes. Many countries face difficulties in diagnosing TB infection,... Read more
Pioneering Collaboration to Transform Pediatric Cancer Diagnostics and Research
Cancer remains the leading cause of disease-related death after infancy in the U.S., despite being rare in children and adolescents. In 2024, nearly 15,000 children and teens were expected to be diagnosed... Read more
Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio
Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more